Industry News
Alchemia raises $10.2m in placement
Alchemia (ASX:ACL) has raised $10.2m in an institutional placement and will seek another $2m via an SPP to help fund its Phase III trial of HA-Irinotecan in colorectal cancer. [ + ]
Pharmaxis completes Bronchitol trial
Pharmaxis (ASX:PXS) shares climbed 15% after the company revealed it had completed a phase III trial of Bronchitol in patients with bronchiectasis. [ + ]
Alchemia granted US patent
Alchemia has been granted a US patent for the use of HA-Irinotecan and its HyACT targeted chemotherapy platform. [ + ]
Positive results for new multiple myeloma treatment
A new treatment for multiple myeloma, developed by Patrys, shows promising results in patients. [ + ]
New guidelines for gender equity in science
The Early and Mid Career Researcher Forum of the Australian Academy of Science has published working guidelines to ensure that women and men have equal opportunities to pursue a successful career in science. [ + ]
Study finds impact craters could have fostered early life
A Curtin University-funded study has revealed that even comparatively small meteorite impact craters might have played a key role in the origin and evolution of early life. [ + ]
Type 1 diabetes testing could become faster, cheaper
Work by Perth researchers could revolutionise testing for type 1 diabetes around the world. [ + ]
Insight into how first life forms were ‘born’
An international team of physicists has revealed insights into how the very first life forms made the jump from the non-living to the living world by mathematically modelling biological states using energy waves called solitons. [ + ]
Acrux’s underarm testosterone listed on PBS
Acrux’s (ASX:ACR) underarm testosterone treatment for androgen deficiency has been added to the PBS, via global licensing partner Eli Lilly. [ + ]
Global biotech crop plantings increase 100-fold
Last year marked an unprecedented 100-fold increase in biotech crop hectarage. [ + ]
Gene patent ruling appealed
Cancer Voices Australia will appeal the Federal Court of Australia’s decision to allow genes to be patented. [ + ]
BioReliance acquires rights to Big Blue colonies and cell lines from Agilent
Sigma-Aldrich Corporation has announced that BioReliance has signed an agreement to acquire the colonies required for the Big Blue transgenic rodent mutation (TRM) assay and to obtain a licence to its associated trademark from Agilent Technologies. [ + ]
Prototype of handheld system for rapid, on-the-spot diagnostic results unveiled
AgPlus Diagnostics has announced that the first functional prototype of the company’s handheld analytical platform is now fully operational and available for demonstration. [ + ]
Legion of Honour awarded to Australian science leader
Professor Kurt Lambeck will today be awarded the Legion of Honour - the highest decoration in France - in recognition of his contribution to the field of science and his strong ties to the country. [ + ]
Stress test for corals
Researchers at the ARC Centre of Excellence for Coral Reef Studies (CoECRS) are developing a test to measure the expression of haemoglobin by the resident microalgae that live within coral. [ + ]
